| Authors: |
Ribi K; International Breast Cancer Study Group (IBCSG), a division of ETOP (European Thoracic Oncology Platform) IBCSG Partners Foundation, Bern, Switzerland.; Careum School of Health, Part of the Kalaidos University of Applied Sciences, Zurich, Switzerland., Cole BF; Department of Mathematics and Statistics, University of Vermont, Burlington, Vermont, USA., Fleming GF; The University of Chicago Medical Center, Chicago, Illinois, USA., Walley BA; University of Calgary and Canadian Cancer Trials Group, Calgary, Alberta, Canada., Francis PA; The Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia.; Breast Cancer Trials Australia and New Zealand, University of Newcastle, Callaghan, Newcastle, Australia., Abdi E; Breast Cancer Trials Australia and New Zealand, The Tweed Hospital Tweed Heads, Griffith University Gold Coast, Newcastle, New South Wales, Australia., Burstein HJ; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Alliance for Clinical Trials in Oncology, Boston, Massachusetts, USA., Cheng KL; Northwell Health Division of Medical Oncology and Hematology, Zucker School of Medicine at Hofstra University, Lake Success, New York, USA., Chia SKL; Division of Medical Oncology, The University of British Columbia and British Columbia Cancer Agency, Vancouver, British Columbia, Canada.; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Dakhil SR; Wichita National Cancer Institute Community Oncology Research Program, Via Christi Regional Medical Center and Cancer Center of Kansas, Wichita, Kansas, USA., Davidson NE; Fred Hutchinson Cancer Center, University of Washington Seattle, Seattle, Washington, USA.; Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group, Philadelphia, Pennsylvania, USA., Della-Fiorentina SA; Macarthur Cancer Center, Campbelltown Hospital, Campbelltown, New South Wales, Australia.; Breast Cancer Trials Australia and New Zealand, Newcastle, New South Wales, Australia., Frith AE; Division of Oncology, John T. Milliken Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Levine E; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Lupichuk S; Arthur J.E.Child Comprehensive Cancer Center, Calgary, Alberta, Canada., Pritchard K; Canadian Cancer Trials Group, Kingston, Ontario, Canada.; Odette Cancer Research Program, Sunnybrook Health Sciences Center, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada., Salim M; Allen Blair Cancer Center, Regina, Saskachewan, Canada., Stearns V; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical School, New York, New York, USA., Stewart J; Breast Cancer Trials Australia and New Zealand, Newcastle, New South Wales, Australia.; Austin Hospital, Heidelberg, Victoria, Australia., Valero V; Breast Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., van der Westhuizen A; Breast Cancer Trials Australia and New Zealand, The Tweed Hospital Tweed Heads, Griffith University Gold Coast, Newcastle, New South Wales, Australia.; Calvary Mater Newcastle Hospital, Waratah, New South Wales, Australia., Pagani O; Geneva University Hospitals, Geneva, Switzerland.; Lugano University, Lugano, Switzerland.; Swiss Group for Clinical Cancer Research, Bern, Switzerland., Loi S; International Breast Cancer Study Group (IBCSG), a division of ETOP (European Thoracic Oncology Platform) IBCSG Partners Foundation, Bern, Switzerland.; The Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia.; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Colleoni M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy., Gelber RD; Division of Biostatistics, Department of Data Science, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Frontier Science Foundation, Boston, Massachusetts, USA.; Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA., Goldhirsch A; International Breast Cancer Study Group (IBCSG), a division of ETOP (European Thoracic Oncology Platform) IBCSG Partners Foundation, Bern, Switzerland.; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.; Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA., Coates AS; International Breast Cancer Study Group (IBCSG), a division of ETOP (European Thoracic Oncology Platform) IBCSG Partners Foundation, Bern, Switzerland.; University of Sydney, Sydney, New South Wales, Australia., Regan MM; IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Bernhard J; International Breast Cancer Study Group (IBCSG), a division of ETOP (European Thoracic Oncology Platform) IBCSG Partners Foundation, Bern, Switzerland. |
